Advancing rare disease measurement through the Rare Disease Clinical Outcome Assessment Consortium
{{output}}
There is a significant unmet need to develop and evaluate new treatments for people living with one of approximately 8000 rare diseases. Well-known difficulties in conducting clinical trials (e.g., small samples, wide geographic distribution, heterogeneous sym... ...
